Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABBV compared with MRK: revenue, margins and what each company keeps, and the suppliers and customers both name
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
MRK
Merck & Co., Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABBV
AbbVie Inc.
vs
MRK
Merck & Co., Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ABBV
0 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 30 '26
±3.5%
▲
+1.41%
×0.40
Q2 FY26
±3.5%
▼
−2.51%
×0.71
Q1 FY26
±4.0%
▲
+3.14%
×0.78
Feb 4 '26
±3.9%
▼
−3.79%
×0.97
MRK
1 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±3.4%
▲
+3.83%
×1.12
Q2 FY26
±4.1%
▲
+0.18%
×0.05
= implied
ABBV realized, solid
MRK realized, hatched
One scale, both sides: full bar = 5%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±3.9%
▼
−1.60%
×0.41
Feb 3 '26
±4.3%
▲
+2.18%
×0.51
ABBV
AbbVie Inc.
Change
288.78
▼
−2.07%
· post 289.89
Mkt cap
$521.1B
Revenue
$17.0B
Q2 FY26
Revenue
$61.2B
FY25
MRK
Merck & Co., Inc.
Change
148.44
▼
−0.72%
· post 149.04
Closed
Nov 2 '26
Mkt cap
$368.9B
Revenue
$16.6B
Q2 FY26
Revenue
$65.0B
FY25
vs
Compare
Closed
Nov 2 '26
ABBV
AbbVie Inc.
vs
MRK
Merck & Co., Inc.
288.78
▼
−2.07%
post 289.89
Price
148.44
▼
−0.72%
post 149.04
$521.1B
Mkt cap
$368.9B
Q2 FY26
$17.0B
Revenue
$16.6B
Q2 FY26
FY25
$61.2B
Revenue
$65.0B
FY25
Change
Change
ABBV
288.78
▼
−2.07%
vs
MRK
148.44
▼
−0.72%
Closed
Nov 2 '26